Biofrontera Reports Full Year 2017 Financial Results
April 30, 2018 08:00 ET
|
Biofrontera AG
Leverkusen, Germany, April 30, 2018 (GLOBE NEWSWIRE) --
Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical...
NetworkNewsWire Announces Publication on Good News in Biotech Advancements Through Cannabis Delivery Technology
April 25, 2018 08:30 ET
|
NetworkNewsWire
NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial...
NetworkNewsAudio Covers Lexaria’s Biotech Breakthrough in Nicotine Delivery
April 20, 2018 06:00 ET
|
NetworkNewsWire
NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for business, today announces the audio version of the...
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine
April 19, 2018 08:00 ET
|
VBI Vaccines, Inc.
More than 1,600 subjects enrolled in PROTECT studyTopline data expected mid-2019 CAMBRIDGE, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”) today announced...
Biofrontera announces preliminary unaudited sales revenues for the 1st Quarter 2018
April 12, 2018 10:53 ET
|
Biofrontera AG
Leverkusen, Germany, April 12, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ:BFRA) (ISIN: DE0006046113), the specialist for the treatment of sun-induced skin cancer, today announced preliminary...
International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results
April 10, 2018 08:45 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based...
Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma
March 14, 2018 09:45 ET
|
Rich Pharmaceuticals
BEVERLY HILLS, CA , March 14, 2018 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology,...
VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange
March 12, 2018 16:15 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. ("VBI" or the "Company") (Nasdaq:VBIV) (TSX:VBV), a commercial-stage biopharmaceutical company developing next-generation...
Pivot Pharma Retains Cannabis Compliance to File Dealer’s License Application on Behalf of Agro-Biotech Inc.
March 12, 2018 03:30 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (FRA:NPAT) (“Pivot” or the “Company”), is pleased to announce...
Pivot Pharma Closes C$5M Private Placement of Convertible Debentures
March 05, 2018 08:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB: PVOTF) (“Pivot” or the “Company”) is pleased to announce the closing...